What is NAMI's operating income?

NAMI's total operating income in 2025 was -$14.91 million, based on the following breakdown: Total Gross Profit: $6.51 million Total Operating Expenses: $21.42 million

NAMI (NAMI) Financials

$3.20 +0.00 (+0.09%)

Closing price 03:58 PM Eastern

Extended Trading

$3.20 +0.00 (+0.06%)

As of 04:34 PM Eastern

Compare

Annual Income Statements for NAMI

This table shows NAMI's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	7.65	9.93	2.78	-13
Consolidated Net Income / (Loss)	7.99	12	4.19	-14
Net Income / (Loss) Continuing Operations	7.99	12	4.19	-14
Total Pre-Tax Income	7.99	12	4.19	-14
Total Operating Income	6.35	11	3.71	-15
Total Gross Profit	14	23	16	6.51
Total Revenue	34	53	56	59
Operating Revenue	34	53	56	59
Total Cost of Revenue	20	31	40	53
Operating Cost of Revenue	20	31	40	53
Total Operating Expenses	7.75	11	12	21
Selling, General & Admin Expense	2.25	3.33	3.26	11
Marketing Expense	1.68	2.92	2.66	3.05
Research & Development Expense	3.82	4.98	6.39	7.45
Total Other Income / (Expense), net	1.64	0.49	0.47	0.51
Interest Expense	0.03	0.00	0.00	0.00
Interest & Investment Income	0.17	0.17	0.32	0.26
Other Income / (Expense), net	1.50	0.31	0.15	0.26
Income Tax Expense	0.00	0.00	0.00	0.01
Net Income / (Loss) Attributable to Noncontrolling Interest	0.34	1.83	1.41	-0.92
Basic Earnings per Share	$0.02	$0.02	$0.01	$0.00
Weighted Average Basic Shares Outstanding	416.92M	416.92M	466.37M	1.25B
Diluted Earnings per Share	$0.02	$0.02	$0.01	$0.00
Weighted Average Diluted Shares Outstanding	466.19M	466.19M	515.64M	1.25B
Weighted Average Basic & Diluted Shares Outstanding	-	-	1.15B	1.42B

No quarterly income statements for NAMI are available.

This table details how cash moves in and out of NAMI's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.49	2.84	2.39	-4.05
Net Cash From Operating Activities	4.86	7.99	3.53	-3.52
Net Cash From Continuing Operating Activities	4.86	7.99	3.53	-3.52
Net Income / (Loss) Continuing Operations	7.99	12	4.19	-14
Consolidated Net Income / (Loss)	7.99	12	4.19	-14
Depreciation Expense	1.65	1.84	4.05	5.54
Non-Cash Adjustments To Reconcile Net Income	-0.04	-0.14	-0.06	4.91
Changes in Operating Assets and Liabilities, net	-4.74	-5.48	-4.65	0.45
Net Cash From Investing Activities	-3.46	-4.31	-4.17	-3.39
Net Cash From Continuing Investing Activities	-3.46	-4.31	-4.17	-3.39
Purchase of Property, Plant & Equipment	-0.10	-0.07	-0.16	-0.11
Acquisitions	-1.33	-1.78	-8.26	-1.43
Purchase of Investments	0.00	0.00	-0.41	-1.00
Sale of Property, Plant & Equipment	0.02	0.00	0.00	0.00
Sale and/or Maturity of Investments	-2.04	-2.46	4.67	-0.85
Net Cash From Financing Activities	0.00	-0.83	3.03	2.65
Net Cash From Continuing Financing Activities	0.00	-0.83	3.03	2.65
Repurchase of Common Equity	0.00	-0.88	0.00	-0.32
Payment of Dividends	0.00	0.03	0.00	0.07
Issuance of Debt	-	0.00	0.00	2.14
Issuance of Common Equity	0.00	0.00	3.03	0.75
Other Financing Activities, net	0.00	0.02	0.00	0.00
Other Net Changes in Cash	-0.91	0.00	0.00	0.20
Cash Interest Paid	0.00	0.00	0.00	0.00
Cash Income Taxes Paid	0.00	0.00	0.00	0.00

No quarterly cash flow statements for NAMI are available.

This table presents NAMI's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	12/31/2023	12/31/2024	12/31/2025
Total Assets	25	33	27
Total Current Assets	21	22	17
Cash & Equivalents	11	13	9.19
Short-Term Investments	6.08	1.24	2.14
Accounts Receivable	2.03	7.49	3.94
Inventories, net	0.64	0.51	0.68
Other Current Assets	1.49	0.35	1.29
Plant, Property, & Equipment, net	0.19	0.27	0.96
Total Noncurrent Assets	3.77	11	9.29
Long-Term Investments	1.17	1.63	2.84
Intangible Assets	1.53	8.46	6.45
Total Liabilities & Shareholders' Equity	25	33	27
Total Liabilities	7.83	11	12
Total Current Liabilities	7.07	10	11
Short-Term Debt	0.00	0.00	2.14
Accounts Payable	1.44	5.21	4.37
Accrued Expenses	-	0.62	0.69
Current Deferred & Payable Income Tax Liabilities	0.76	0.62	0.48
Other Current Liabilities	4.87	3.79	3.59
Total Noncurrent Liabilities	0.76	0.64	0.52
Capital Lease Obligations	-	-	0.26
Other Noncurrent Operating Liabilities	0.76	0.64	0.26
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-17	22	16
Total Preferred & Common Equity	-20	18	12
Total Common Equity	-20	18	12
Common Stock	1.88	37	45
Retained Earnings	-23	-20	-34
Accumulated Other Comprehensive Income / (Loss)	0.06	0.05	0.27
Other Equity Adjustments	0.74	1.02	1.09
Noncontrolling Interest	3.04	4.36	3.71

No quarterly balance sheets for NAMI are available.

This table displays calculated financial ratios and metrics derived from NAMI's official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	0.00	-	0.00
DEI Adjusted Shares Outstanding	0.00	0.00	-	0.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.00	-	0.00
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	56.05%	4.07%	6.08%
EBITDA Growth	0.00%	41.35%	-41.08%	-215.07%
EBIT Growth	0.00%	47.68%	-66.67%	-479.22%
NOPAT Growth	0.00%	77.64%	-67.05%	-380.94%
Net Income Growth	0.00%	47.26%	-64.40%	-444.23%
EPS Growth	0.00%	32.70%	-73.93%	-125.45%
Operating Cash Flow Growth	0.00%	64.24%	-55.80%	-199.59%
Free Cash Flow Firm Growth	0.00%	0.00%	-133.35%	-84.51%
Invested Capital Growth	0.00%	0.00%	879.45%	-42.91%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	41.13%	42.06%	28.78%	11.03%
EBITDA Margin	27.72%	25.10%	14.21%	-15.42%
Operating Margin	18.51%	21.08%	6.67%	-25.24%
EBIT Margin	22.89%	21.66%	6.94%	-24.80%
Profit (Net Income) Margin	23.30%	21.98%	7.52%	-24.40%
Tax Burden Percent	100.00%	99.97%	100.00%	100.10%
Interest Burden Percent	101.77%	101.50%	108.38%	98.28%
Effective Tax Rate	0.00%	0.03%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	123.77%	-192.95%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	120.94%	-163.86%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-102.51%	117.39%
Return on Equity (ROE)	0.00%	69.38%	21.26%	-75.56%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-58.88%	-138.32%
Operating Return on Assets (OROA)	0.00%	46.77%	13.30%	-48.17%
Return on Assets (ROA)	0.00%	47.46%	14.41%	-47.39%
Return on Common Equity (ROCE)	0.00%	-82.26%	-1.09%	-59.58%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	23.16%	0.00%
Net Operating Profit after Tax (NOPAT)	6.35	11	3.71	-10
NOPAT Margin	18.51%	21.07%	6.67%	-17.67%
Net Nonoperating Expense Percent (NNEP)	0.00%	5.46%	2.83%	-29.10%
Return On Investment Capital (ROIC_SIMPLE)	-	-66.11%	16.55%	-57.63%
Cost of Revenue to Revenue	58.87%	57.94%	71.22%	88.97%
SG&A Expenses to Revenue	6.58%	6.22%	5.85%	18.49%
R&D to Revenue	11.15%	9.30%	11.47%	12.61%
Operating Expenses to Revenue	22.62%	20.99%	22.10%	36.27%
Earnings before Interest and Taxes (EBIT)	7.85	12	3.86	-15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	9.50	13	7.91	-9.11
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	116.36	79.77
Price to Tangible Book Value (P/TBV)	0.00	0.00	218.63	172.65
Price to Revenue (P/Rev)	0.15	0.09	37.79	16.20
Price to Earnings (P/E)	0.65	0.50	757.55	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	153.00%	198.59%	0.13%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	303.91	241.30
Enterprise Value to Revenue (EV/Rev)	0.00	0.45	37.59	16.06
Enterprise Value to EBITDA (EV/EBITDA)	0.00	1.80	264.46	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	2.09	541.71	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	2.15	563.37	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	3.03	592.84	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	1.99	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.15
Long-Term Debt to Equity	0.00	0.00	0.00	0.02
Financial Leverage	0.00	-1.05	-0.85	-0.72
Leverage Ratio	0.00	1.46	1.48	1.59
Compound Leverage Factor	0.00	1.48	1.60	1.57
Debt to Total Capital	0.00%	0.01%	0.00%	13.30%
Short-Term Debt to Total Capital	0.00%	0.01%	0.00%	11.85%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	1.45%
Preferred Equity to Total Capital	0.00%	0.02%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	218.53%	19.45%	20.47%
Common Equity to Total Capital	0.00%	-118.55%	80.55%	66.23%
Debt to EBITDA	0.00	0.00	0.00	-0.26
Net Debt to EBITDA	0.00	-1.33	-1.97	1.29
Long-Term Debt to EBITDA	0.00	0.00	0.00	-0.03
Debt to NOPAT	0.00	0.00	0.00	-0.23
Net Debt to NOPAT	0.00	-1.58	-4.19	1.13
Long-Term Debt to NOPAT	0.00	0.00	0.00	-0.03
Altman Z-Score	0.00	3.47	117.63	47.58
Noncontrolling Interest Sharing Ratio	0.00%	218.56%	105.11%	21.16%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	2.95	2.17	1.53
Quick Ratio	0.00	2.64	2.09	1.35
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	12	-4.05	-7.48
Operating Cash Flow to CapEx	5,832.12%	11,961.06%	2,228.81%	-3,135.70%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-1,634.84
Operating Cash Flow to Interest Expense	166.02	0.00	0.00	-768.24
Operating Cash Flow Less CapEx to Interest Expense	163.17	0.00	0.00	-792.74
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	2.16	1.92	1.94
Accounts Receivable Turnover	0.00	26.32	11.70	10.34
Inventory Turnover	0.00	48.66	69.06	87.88
Fixed Asset Turnover	0.00	288.84	247.06	96.70
Accounts Payable Turnover	0.00	21.53	11.93	10.97
Days Sales Outstanding (DSO)	0.00	13.87	31.20	35.29
Days Inventory Outstanding (DIO)	0.00	7.50	5.29	4.15
Days Payable Outstanding (DPO)	0.00	16.95	30.60	33.28
Cash Conversion Cycle (CCC)	0.00	4.42	5.89	6.17
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	-0.88	6.89	3.93
Invested Capital Turnover	0.00	-121.12	18.55	10.92
Increase / (Decrease) in Invested Capital	0.00	-0.88	7.77	-2.95
Enterprise Value (EV)	0.00	24	2,093	949
Market Capitalization	5.00	5.00	2,104	957
Book Value per Share	$0.00	($0.05)	$0.04	$0.01
Tangible Book Value per Share	$0.00	($0.05)	$0.02	$0.00
Total Capital	0.00	17	22	18
Total Debt	0.00	0.00	0.00	2.41
Total Long-Term Debt	0.00	0.00	0.00	0.26
Net Debt	0.00	-18	-16	-12
Capital Expenditures (CapEx)	0.08	0.07	0.16	0.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-2.91	-1.90	-3.22
Debt-free Net Working Capital (DFNWC)	0.00	14	12	8.11
Net Working Capital (NWC)	0.00	14	12	5.97
Net Nonoperating Expense (NNE)	-1.64	-0.49	-0.47	3.98
Net Nonoperating Obligations (NNO)	0.00	-18	-16	-12
Total Depreciation and Amortization (D&A)	1.65	1.84	4.05	5.54
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-5.43%	-3.41%	-5.45%
Debt-free Net Working Capital to Revenue	0.00%	25.71%	21.60%	13.74%
Net Working Capital to Revenue	0.00%	25.71%	21.60%	10.11%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	466.37M	1.25B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.01	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	515.64M	1.25B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	1.15B	1.42B
Normalized Net Operating Profit after Tax (NOPAT)	4.44	11	2.60	-10
Normalized NOPAT Margin	12.96%	21.07%	4.67%	-17.67%
Pre Tax Income Margin	23.30%	21.99%	7.52%	-24.38%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	267.94	0.00	0.00	-3,201.27
NOPAT to Interest Expense	216.68	0.00	0.00	-2,280.50
EBIT Less CapEx to Interest Expense	265.09	0.00	0.00	-3,225.77
NOPAT Less CapEx to Interest Expense	213.83	0.00	0.00	-2,305.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	-0.24%	0.00%	0.49%
Augmented Payout Ratio	0.00%	7.22%	0.00%	-1.73%

No quarterly metrics and ratios for NAMI are available.

Financials Breakdown Chart

NAMI Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NAMI's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

NAMI's net income appears to be on a downward trend, with a most recent value of -$14.41 million in 2025, falling from $7.99 million in 2022. The previous period was $4.19 million in 2024. See where experts think NAMI is headed by visiting NAMI's forecast page.

NAMI's total operating income in 2025 was -$14.91 million, based on the following breakdown:

Total Gross Profit: $6.51 million
Total Operating Expenses: $21.42 million

Over the last 3 years, NAMI's total revenue changed from $34.28 million in 2022 to $59.06 million in 2025, a change of 72.3%.

NAMI's total liabilities were at $11.79 million at the end of 2025, a 8.4% increase from 2024, and a 50.7% increase since 2023.

In the past 2 years, NAMI's cash and equivalents has ranged from $9.19 million in 2025 to $12.68 million in 2024, and is currently $9.19 million as of their latest financial filing in 2025.

Over the last 3 years, NAMI's book value per share changed from 0.00 in 2022 to 0.01 in 2025, a change of 1.0%.

Related Companies

Financial statements for NASDAQ:NAMI last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NAMI (NAMI) Financials

Financials Breakdown Chart

NAMI Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NAMI (NAMI) Financials

Annual Income Statements for NAMI

Quarterly Income Statements for NAMI

Annual Cash Flow Statements for NAMI

Quarterly Cash Flow Statements for NAMI

Annual Balance Sheets for NAMI

Quarterly Balance Sheets for NAMI

Annual Metrics And Ratios for NAMI

Quarterly Metrics And Ratios for NAMI

Financials Breakdown Chart

NAMI Financials - Frequently Asked Questions

When does NAMI's fiscal year end?

How has NAMI's net income changed over the last 3 years?

What is NAMI's operating income?

How has NAMI's revenue changed over the last 3 years?

How much debt does NAMI have?

How much cash does NAMI have?

How has NAMI's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools